Dickkopf-1 (DKK-1)

More Novel Tests

References

Ahmed, S. F. (2013). Serum dickkopf-1 level in postmenopausal females: correlation with bone mineral density and serum biochemical markers. Journal of Osteoporosis, 460210.Anastasilakis, A. D. (2010). The effect of teriparatide on serum Dickkopf-1 levels in postmenopausal women with established osteoporosis. Clinical Endocrinology, 752-757.Begenik, H. K. (2014). The association between serum Dickkopf-1 levels and esophageal squamous cell carcinoma. Human & Experimental Toxicology, 785-788.Chu, T. T. (2014). Lung cancer-derived Dickkopf1 is associated with bone metastasis and the mechanism involves the inhibition of osteoblast differentiation. Biochemical and Biophysical Research Communications, 962-968.Chung, Y. L. (2021). Elevated serum Dickkopf-1 is a biomarker for bone erosion in patients with psoriatic arthritis. Chinese Medical Journal, 2583-2588.Coulson, J. B. (2017). Circulating levels of dickkopf-1, osteoprotegerin and sclerostin are higher in old compared with young men and women and positively associated with whole-body bone mineral density in older adults. Osteoporosis International, 2683-2689.Czepiel, M. S. (2021). Down-regulation of Dkk-1 in platelets of patients with axial spondyloarthritis. Arthritis & Rheumatology, 1831-1834.Daigo, Y. (2007). Dikkopf-1 as a novel serologic and prognostic biomarker for lung and esophageal carcinomas. Cancer Research, 2517-2525.D'Amelio, P. R. (2014). DKK-1 in prostate cancer diagnosis and follow up. BMC Clinical Pathology, 11.Daoussis, D. L. (2010). Evidence that Dkk-1 is dysfunctional in ankylosing spondylitis. Arthritis and Rheumatism, 150-158.Diarra, D. S. (2007). Dickkopf-1 is a master regulator of joint remodeling. Nature Medicine, 156-163.Dong, L. L. (2014). Serum level of DKK-1 and its prognostic potential in non-small cell lung cancer. Diagnostic Pathology.Fassio, A. I. (2017). In psoriatic arthritis Dkk-1 and PTH are lower than in rheumatoid arthritis and healthy controls. Clinical Rheumatology, 2377-2381.Hajialilo, M. R. (2013). Dickkopf-1 levels and serum osteoprotegerin in women with osteoporosis. Journal of Research in Clinical Medicine, 68-74.Han, S. X. (2015). Serum dickkopf-1 is a novel serological biomarker for the diagnosis and prognosis of pancreatic cancer. Oncotarget, 19907-19917.Honsawek, S. T. (2010). Dickkopf-1 (Dkk-1) in plasma and synovial fluid is inversely correlated wtih radiographic severity of knee osteoarthritis patients. BMC Musculoskeletal Disorders, 257.Hu, Z. X. (2012). Adalimumab significantly reduces inflammation and serum DKK-1 level but increases fatty deposition in lumbar spine in active ankylosing spondylitis. International Journal of Rheumatic Diseases, 358-365.Ibrahim, N. H. (2020). Study of serum and synovial fluid Dickkopf-1 levels in patients with primary osteoarthritis of the knee joint in correlation with disease activity and severity. Egyptian Rheumatology and Rehabilitation, 1-6.Idriss, N. K. (2020). Joint remodeling outcome of serum levels of Dickkopf-1 (DKK1), cartilage oligomeric matrix protein (COMP), and C-telopeptide of type II collagen (CTXII) in rheumatoid arthritis. Central-European Journal of Immunology, 73-79.Jiang, X. T. (2014). Assessing the diagnostic value of serum Dickkopf-related protein 1 levels in cancer detection: a case-control study and meta-analysis. Asian Pacific Journal of Cancer Prevention, 9077-9083.Jo, S. N. (2021). The TNF-NF-κB-DKK1 axis promoted bone formation in the enthesis of ankylosing spondylitis. Journal of Rheumatic Diseases, 216-224.Kagey, M. H. (2017). Rationale for targeting the Wnt signalling modulator Dickkopf-1 for oncology. British Journal of Pharmacology, 4637-4650.Klotz, D. M. (2021). Evaluation of circulating Dickkopf-1 as a prognostic biomarker in ovarian cancer patients. Clinical Chemistry and Laboratory Medicine, 109-117.Kwon, S. R. (2012). Dickkopf-1 level is lower in patients with ankylosing spondylitis than in healthy people and is not influenced by anti-tumor necrosis factor therapy. Rheumatology International , 2523-2527.Lang, J. Z. (2018). Bone turnover markers and novel biomarkers in lung cancer bone metastases. Biomarkers, 518-526.Lee, H. S. (2012). Clinical significance of serum and tissue Dickkopf-1 levels in patients with gastric cancer. Clinica Chimica Acta, 1753-1760.Li, Z. M. (2019). Diagnostic accuracy of serum dickkopf-1 protein in diagnosis hepatocellular carcinoma: an updated meta-analysis. Medicine, e16725.Liang, B. Z. (2015). Serum dickkopf-1 as a biomarker in screening gastrointestinal cancers: a systematic review and meta-analysis. OncoTargets and Therapy, 3115-3122.Liu, J. T. (2017). Serum Dickkopf-1 acts as a new biomarker in human breast cancer. Minerva Medica, 334-340.Liu, Q. R. (2016). Prognostic significance of dickkopf-1 in gastric cancer survival: a meta-analysis. Genetic Testing and Molecular Biomarkers, 170-175.Liu, Y. Y. (2010). Circulating Dickkopf-1 and osteoprotegerin in patients with early and longstanding rheumatoid arthritis. Chinese Medical Journal, 1407-1412.Ma, Y. Z. (2018). The serum level of Dickkopf-1 in patients with rheumatoid arthritis: A systematic review and meta-analysis. International Immunopharmacology, 227-232.Min, S. W. (2017). Serum levels of the bone turnover markers dickkopf-1, osteoprotegerin and TNF-α in knee osteoarthritis patients. Clinical Rheumatology, 2351-2358.N Zekri, A. R. (2020). The possible role of Dickkopf-1, Golgi protein-73 and Midkine as predictors of hepatocarcinogenesis: a review and an Egyptian study. Scientific Reports, 5156.Niu, C. C. (2017). Correlation of blood bone turnover biomarkers and Wnt signaling antagonists with AS, DISH, OPLL and OYL. BMC Musculoskeletal Disorders, 61.Nocturne, G. P. (2015). Increase in Dickkopf-1 serum level in recent spondyloarthritis. Data from the DESIR cohort. PLOS One, e0134974.Orsolini, G. A. (2018). Parathyroid hormone is a determinant of serum Dickkopf-1 levels in ankylosing spondylitis. Clinical Rheumatology, 3093-3098.Peng, Y. H. (2016). Combined detection of serum Dickkopf-1 and its autoantibodies to diagnose esophageal squamous cell carcinoma. Cancer Medicine, 1388-1396.Rachner, T. D. (2014). High serum levels of Dickkopf-1 are associated with a poor prognosis in prostate cancer patients. BMC Cancer, 649.Ramirez, J. G. (2021). High serum levels of Wnt signaling antagonist Dickkopf-related protein 1 are associated with impaired overall survival and recurrence in esophageal cancer patients. Cancers, 4980.Roato, I. D. (2008). Osteoclasts are active in bone forming metastases of prostate cancer patients. PLOS One, e3627.Rossini, M. V. (2015). In patients with rheumatoid arthritis, Dickkopf-1 serum levels are correlated with parathyroid hormone, bone erosions and bone mineral density. Clinical and Experimental Rheumatology, 77-83.Rossini, M. V. (2016). Higher level of dickkopf-1 is associated with low bone mineral density and higher prevalence of vertebral fractures in patients with ankylosing spondylitis. Calcified Tissue International, 438-445.Ruaro, B. C. (2018). Dickkopf-1 (DKK-1) serum levels in systemic sclerosis and rheumatoid arthritis patients: correlation with the Trabecular Bone Score (TBS). Clinical Rheumatology, 3057-3062.Sato, N. Y. (2010). Wnt inhibitor Dickkopf-1 as a target for passive cancer immunotherapy. Cancer Research, 5326-5336.Shen, Q. F. (2012). Serum DKK1 as a protein biomarker for the diagnosis of hepatocellular carcinoma: a large-scale, multicentre study. The Lancet Oncology, 817-826.Sheng, S. L. (2009). Clinical significance and prognostic value of serum Dickkopf-1 concentrations in patients with lung cancer. Clinical Chemistry, 1656-1664.Shizhuo, W. T. (2009). The expression and significance of Dickkopf-1 in epithelial ovarian carcinoma. The International Journal of Biological Markers, 165-170.Sun, J. C. (2020). Comparison of the diagnostic value of CEA combined with OPN or DKK1 in non-small cell lung cancer. Oncology Letters, 3046-3052.Sun, W. T. (2019). Sclerostin rather than Dickkopf-1 is associated with mSASSS but not with disease activity score in patients with ankylosing spondylitis. Clinical Rheumatology, 989-995.Tian, J. X. (2015). Association of serum Dkk-1 levels with β-catenin in patients with postmenopausal osteoporosis. Journal of Huazhong University of Science and Technology [Medical Sciences], 212-218.Voorzanger-Rousselot, N. B. (2009). Opposite relationships between circulating Dkk-1 and cartilage breakdown in patients with rheumatoid arthritis and knee osteoarthritis. Annals of the Rheumatic Diseases, 1513-1514.Voskaridou, E. C. (2009). Serum Dickkopf-1 is increased and correlates with reduced bone mineral density in patients with thalassemia-induced osteoporosis. Reduction post-zoledronic acid administration. Haematologica, 725-728.Wang, N. X. (2018). Role of sclerostin and dkk1 in bone remodeling in type 2 diabetic patients. Endocrine Research, 29-38.Wang, S. Y. (2011). Circulating Dickkopf-1 is correlated with bone erosion and inflammation in rheumatoid arthritis. The Journal of Rheumatology, 821-827.Wang, Y. C. (2022). Clinical value of combined detection of serum CA724, DKK1, and TK1 in diagnosis of gastric cancer. Journal of Oncology, 6941748.Yamabuki, T. T. (2007). Dikkopf-1 as a novel serologic and prognostic biomarker for lung and esophageal carcinomas. Cancer Research, 2517-2525.Yang, H. C. (2013). Dickkopf-1: as a diagnostic and prognostic serum marker for early hepatocellular carcinoma. The International Journal of Biological Markers, 286-297.Yucong, Z. L. (2014). Sreum functional dickkopf-1 levels are inversely correlated with radiographic severity of ankylosing spondylitis. Clinical Laboratory, 1527-1531.Zhang, J. Z. (2014). Sensitivity and specificity of Dickkopf-1 protein in serum for diagnosing hepatocellular carcinoma: a meta-analysis. The International Journal of Biological Markers, e403-e410.Zhang, L. O. (2016). Serum DKK-1 level in the development of ankylosing spondylitis and rheumatic arthritis: a meta-analysis. Experimental & Molecular Medicine, e228.Zhou, S. J. (2014). Serum Dickkopf-1 expression level positively correlates with a poor prognosis in breast cancer. Diagnostic Pathology, 161.